ISIN | LU2402148493 |
---|---|
Valor Number | 114551773 |
Bloomberg Global ID | UBHCUHP LX |
Fund Name | UBS (Lux) Equity Fund - Sustainable Health Transformation (USD) (CHF hedged) P-acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS Global Asset Management Basel Phone: +41 61 288 20 20 |
Asset Class | Equities |
EFC Category | Equity Health Care |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The Fund’s investment objective consists in generating strong capital appreciation with a reasonable level of income, while giving due consideration to capital security and the liquidity of the Fund’s assets. This sub-fund is a Sustainability Focus Fund. This sub-fund promotes environmental and/or social characteristics and complies with Article 8 of Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector (“SFDR”). This actively managed sub-fund invests at least two thirds of its assets worldwide in shares or other equity interests of companies in developed or emerging markets, which mainly promote United Nations Sustainable Development Goal 3 (Good Health and Well-Being). The focus is on companies that capitalise on healthcare transformation. |
Peculiarities |
Current Price * | 87.45 CHF | 17.04.2025 |
---|---|---|
Previous Price * | 88.22 CHF | 16.04.2025 |
52 Week High * | 104.15 CHF | 23.08.2024 |
52 Week Low * | 83.70 CHF | 07.04.2025 |
NAV * | 87.45 CHF | 17.04.2025 |
Issue Price * | 87.45 CHF | 17.04.2025 |
Redemption Price * | 87.45 CHF | 17.04.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 205,498,398 | |
Unit/Share Assets *** | 4,284,238 | |
Trading Information SIX |
YTD Performance | -3.42% |
31.12.2024 - 17.04.2025
31.12.2024 17.04.2025 |
---|---|---|
1 month | -5.99% |
17.03.2025 - 17.04.2025
17.03.2025 17.04.2025 |
3 months | -5.15% |
17.01.2025 - 17.04.2025
17.01.2025 17.04.2025 |
6 months | -12.07% |
17.10.2024 - 17.04.2025
17.10.2024 17.04.2025 |
1 year | -2.04% |
17.04.2024 - 17.04.2025
17.04.2024 17.04.2025 |
2 years | -3.71% |
17.04.2023 - 17.04.2025
17.04.2023 17.04.2025 |
3 years | -12.56% |
19.04.2022 - 17.04.2025
19.04.2022 17.04.2025 |
5 years | -12.55% |
24.11.2021 - 17.04.2025
24.11.2021 17.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
UnitedHealth Group Inc | 10.23% | |
---|---|---|
Eli Lilly and Co | 9.65% | |
AstraZeneca PLC | 6.77% | |
Bristol-Myers Squibb Co | 5.27% | |
Koninklijke Philips NV | 5.18% | |
Intuitive Surgical Inc | 5.02% | |
Alcon Inc | 4.84% | |
Sandoz Group AG Registered Shares | 4.25% | |
Novartis AG Registered Shares | 4.06% | |
Chugai Pharmaceutical Co Ltd | 4.03% | |
Last data update | 31.03.2025 |
TER | 1.85% |
---|---|
TER date | 30.11.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 1.41% |
Ongoing Charges *** | 1.83% |
SRRI ***
|
|
SRRI date *** |